161 related articles for article (PubMed ID: 37796646)
21. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
22. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.
Chen JX; Rose S; White SB; El-Haddad G; Fidelman N; Yarmohammadi H; Hwang W; Sze DY; Kothary N; Stashek K; Wileyto EP; Salem R; Metz DC; Soulen MC
Cardiovasc Intervent Radiol; 2017 Jan; 40(1):69-80. PubMed ID: 27738818
[TBL] [Abstract][Full Text] [Related]
23. Soluble Fas (CD95) is a prognostic factor in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous stem cell transplantation.
Bewick M; Conlon M; Parissenti AM; Lee H; Zhang L; Glück S; Lafrenie RM
J Hematother Stem Cell Res; 2001 Dec; 10(6):759-68. PubMed ID: 11798502
[TBL] [Abstract][Full Text] [Related]
24. Primary tumor location and the prognosis of patients after local treatment of colorectal liver metastases: a systematic review and meta-analysis.
Buisman FE; Galjart B; Buettner S; Groot Koerkamp B; Grünhagen DJ; Verhoef C
HPB (Oxford); 2020 Mar; 22(3):351-357. PubMed ID: 31668753
[TBL] [Abstract][Full Text] [Related]
25. Survival after repeat hepatectomy for recurrent colorectal liver metastasis: A review and meta-analysis of prognostic factors.
Wang SJ; Si XY; Cai ZB; Zhou YM
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):313-320. PubMed ID: 30826293
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis.
Li C; Fan H; Xiang Q; Xu L; Zhang Z; Liu Q; Zhang T; Ling J; Zhou Y; Zhao X; Cui Y
Breast Cancer Res Treat; 2019 Dec; 178(3):497-504. PubMed ID: 31471838
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysis.
Petrelli F; Coinu A; Zaniboni A; Pietrantonio F; Barni S
Rev Recent Clin Trials; 2016; 11(1):56-62. PubMed ID: 26282898
[TBL] [Abstract][Full Text] [Related]
28. Influence of thermal ablation of hepatic metastases from gastric adenocarcinoma on long-term survival: Systematic review and pooled analysis.
Tang K; Liu Y; Dong L; Zhang B; Wang L; Chen J; Chen G; Tang Z
Medicine (Baltimore); 2018 Dec; 97(49):e13525. PubMed ID: 30544454
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for overall survival in metastatic colorectal cancer using a stop-and-go FLIRI-based treatment strategy.
Kronborg CS; Jensen AR
Int J Colorectal Dis; 2015 Aug; 30(8):1059-65. PubMed ID: 26002752
[TBL] [Abstract][Full Text] [Related]
30. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract][Full Text] [Related]
31. Microvessel density in unknown primary tumors.
Hillen HF; Hak LE; Joosten-Achjanie SR; Arends JW
Int J Cancer; 1997 Feb; 74(1):81-5. PubMed ID: 9036874
[TBL] [Abstract][Full Text] [Related]
32. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
Soran A; Ozbas S; Ozcinar B; Isik A; Dogan L; Senol K; Dag A; Karanlik H; Aytac O; Karadeniz Cakmak G; Dalci K; Dogan M; Sezer YA; Gokgoz S; Ozyar E; Sezgin E;
Ann Surg Oncol; 2022 Oct; 29(10):6327-6336. PubMed ID: 35876920
[TBL] [Abstract][Full Text] [Related]
33. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.
Fan J; Chen D; Du H; Shen C; Che G
J Thorac Dis; 2015 Aug; 7(8):1441-51. PubMed ID: 26380770
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.
Blanchette PS; Desautels DN; Pond GR; Bartlett JMS; Nofech-Mozes S; Yaffe MJ; Pritchard KI
Breast Cancer Res Treat; 2018 Jul; 170(1):169-177. PubMed ID: 29520532
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
37. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
38. Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis.
Dos Santos ES; Rodrigues-Fernandes CI; Speight PM; Khurram SA; Alsanie I; Costa Normando AG; Prado-Ribeiro AC; Brandão TB; Kowalski LP; Silva Guerra EN; Lopes MA; Vargas PA; Santos-Silva AR; Leme AFP
Crit Rev Oncol Hematol; 2021 Jun; 162():103352. PubMed ID: 33991662
[TBL] [Abstract][Full Text] [Related]
39. Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients.
Mariani P; Servois V; De Rycke Y; Bennett SP; Feron JG; Almubarak MM; Reyal F; Baranger B; Pierga JY; Salmon RJ
Eur J Surg Oncol; 2013 Dec; 39(12):1377-83. PubMed ID: 24126165
[TBL] [Abstract][Full Text] [Related]
40. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Hong JC; Ayala-Peacock DN; Lee J; Blackstock AW; Okunieff P; Sung MW; Weichselbaum RR; Kao J; Urbanic JJ; Milano MT; Chmura SJ; Salama JK
PLoS One; 2018; 13(4):e0195149. PubMed ID: 29649281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
